It is not quite clear to me what the book value per share is for NN: Equity of €35 000m / 325m shares outstanding is €107 ?? Stock price EUR 36......
SECTOR: [FAIL] NN is an insurance company and therefore this methodology is not applicable.
SALES: [PASS] The investor must select companies of "adequate size". This includes companies with annual sales greater than €260 million. NN's sales (premiums) of €12 064 million, based on 2017 sales, passes this test.
LONG-TERM DEBT IN RELATION TO NET CURRENT ASSETS: not applicable.
LONG-TERM EPS GROWTH: [FAIL] Companies must increase their EPS by at least 30% over a ten-year period and EPS must not have been negative for any year within the last 5 years. Companies with this type of growth tend to be financially secure and have proven themselves over time. NN does not have a long enough track record as an independent company. The IPO was in 2014.
EARNINGS YIELD: [PASS] The Earnings/Price (inverse P/E) %, based on the lesser of the current Earnings Yield or the Yield using average earnings over the last 3 fiscal years, must be "acceptable", which this methodology states is greater than 6,5%. Stocks with higher earnings yields are more defensive by nature. NN's E/P of 15% (using the average of last 3 years earnings) passes this test.
DIVIDEND €1,90/€36 = 5%
Conclusion 2019: Seems cheap. Outside my circle of compentence.